1.35
price up icon0.75%   0.01
pre-market  Vorhandelsmarkt:  1.38   0.03   +2.22%
loading

Finanzdaten der Cognition Therapeutics Inc-Aktie (CGTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.47%
13.98
13.78 10.72 14.46 14.68
Operating Income/Loss
1.47%
-13.98
-13.78 -10.72 -14.46 -14.68
Income/Loss From Continuing Operations Before Tax
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Income/Loss From Continuing Operations After Tax
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Net Income/Loss
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.01%
63.69
61.83 1.6495 40.42 40.06
Diluted Average Shares
3.01%
63.69
61.83 1.6495 40.42 40.06
Basic Earnings Per Share
21.43%
-0.11
-0.14 -0.17 -0.25 -0.18
Diluted Earnings Per Share
21.43%
-0.11
-0.14 -0.17 -0.25 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.77
price down icon 1.30%
$84.16
price down icon 0.45%
$29.45
price up icon 2.51%
$99.75
price up icon 1.51%
$141.00
price down icon 3.01%
biotechnology ONC
$329.84
price up icon 0.23%
Kapitalisierung:     |  Volumen (24h):